PaLDiSPOT is used for detection and determination of different Borrelia, Babesia and Bartonella genospecies using sensitive molecular biology techniques (quantitative Polymerase Chain Rreaction – qPCR).
Read moreThe PaldiSpot test analyses DNA extracted from your patients’ blood and serum to screen more than 20 of the most common strains of Lyme disease (Borrelia, Babesia and Bartonella genospecies).
Read morePaldiSpot is based on qPCR, where the foreign DNA can be detected and quantified in parallel.
Read moreWhite cells isolated and serum is collected from blood sample. DNA is then isolated and used as template in qPCR reactions.
Read moreDuring the PaldiSpot test, a patient’s DNA is isolated from blood cells and serum. DNA is used as template in qPCR reactions, using appropriate positive and negative controls. Internal controls
Read moreThe patient’s DNA is used in quantitative polymerase chain reaction (qPCR) testing, where we screen the sample for the presence of Borrelia, Babesia or Bartonella DNA. qPCR is an advanced
Read moreAll reactions are performed in triplicate. In addition positive DNA controls for every strain, as well appropriate negative controls ensure accurate and reliable results.
Read moreThe final PaldiSpot test report provides information on whether a specific strain is present in a patient’s cells or serum, and a quantification parameter (its Ct value, or threshold cycle).
Read moreThe threshold cycle, or Ct value, shows that a detectable amount of the DNA has been generated during the test. The PaldiSpot test can detect the presence of 23 strains
Read morePaldiSpot test results are processed and returned within 14 days.
Read more
